ARMP as of Oct 30 · 22:18 ET
ARMPNYSEBiological Products, (No Diagnostic Substances)

Armata Pharmaceuticals, Inc. · Brief

Next report

11 days

Nov 11 · after closeest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26±55.9%▲+11.83%×0.21
quarterimplied−60%0+60%realized×
Q2 FY26±55.9%▲+11.83%×0.21
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 11 report · est.

Bull2

10supplier and customer ties disclosed with other companiesSEC filings
53managers reporting a position in the latest quarter13F · Jun 30 '26

Bear1

3 of 16largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Oct 26 '26once per report · top 2 per case

Linked exposure

ARMP report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 28impliedImplied move: ±56.2% into Nov 11 earnings (Oct 28 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.